VTA neurons show a potentially protective transcriptional response to MPTP.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Brain Research

• Publication date

  2010-07-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.brainres.2010.04.061PMID 20462502
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation of Phosphatidylinositol-Linked D1-Like Receptor Modulates FGF-2 Expression in Astrocytes via IP3-Dependent Ca2+ Signaling

  2009cited by this paper
• Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson's disease.

  2008cited by this paper
• Oxidative stress and the pathogenesis of neurodegenerative disorders.

  2007cited by this paper
• Gene expression profiles of brain dopamine neurons and relevance to neuropsychiatric disease

  2006cited by this paper
• Dynamic HIF1A Regulation During Human Placental Development1

  2006cited by this paper
• Gene expression profiling of rat midbrain dopamine neurons: implications for selective vulnerability in parkinsonism.

  2005cited by this paper
• Gene Expression Profiling of Sporadic Parkinson's Disease Substantia Nigra Pars Compacta Reveals Impairment of Ubiquitin‐Proteasome Subunits, SKP1A, Aldehyde Dehydrogenase, and Chaperone HSC‐70

  2005influential reference
• Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection.

  2005cited by this paper
• The biochemistry of Parkinson's disease.

  2005cited by this paper
• Altered Neuronal Mitochondrial Coenzyme A Synthesis in Neurodegeneration with Brain Iron Accumulation Caused by Abnormal Processing, Stability, and Catalytic Activity of Mutant Pantothenate Kinase 2

  2005cited by this paper
• The HERC proteins: functional and evolutionary insights

  2005cited by this paper
• Altered Gene Expression Profiles Reveal Similarities and Differences Between Parkinson Disease and Model Systems

  2005cited by this paper
• Mutant carbonic anhydrase 4 impairs pH regulation and causes retinal photoreceptor degeneration.

  2005cited by this paper
• Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons

  2004cited by this paper
• Dysregulation of Gene Expression in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Mouse Substantia Nigra

  2004cited by this paper
• PHD domains and E3 ubiquitin ligases: viruses make the connection.

  2003cited by this paper
• Parkinson's Disease Mechanisms and Models

  2003cited by this paper
• No evidence for PHD fingers as ubiquitin ligases.

  2003cited by this paper
• The human tyrosine hydroxylase gene promoter.

  2003cited by this paper
• The PHD domain of MEKK1 acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1/2.

  2002cited by this paper
• The biosynthesis of coenzyme A in bacteria.

  2001cited by this paper
• C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.

  2001cited by this paper
• The psychopharmacology of tachykinin NK-3 receptors in laboratory animals.

  2000cited by this paper
• Girk2 expression in the ventral midbrain, cerebellum, and olfactory bulb and its relationship to the murine mutation weaver.

  1998cited by this paper
• Carbonic anhydrase III protects cells from hydrogen peroxide‐induced apoptosis

  1998cited by this paper
• Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice.

  1997influential reference
• Calcium-binding proteins in the substantia nigra and ventral tegmental area during development: correlation with dopaminergic compartmentalization.

  1997cited by this paper
• Dopamine Transporter Is Required for In Vivo MPTP Neurotoxicity: Evidence from Mice Lacking the Transporter

  1997cited by this paper
• Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration.

  1996cited by this paper
• Human carbonic anhydrases and carbonic anhydrase deficiencies.

  1995cited by this paper
• 1-Methyl-4-phenyl-pyridinium (MPP+) uptake does not explain the differential toxicity of MPP+ in the nigrostriatal and mesolimbic dopaminergic pathways.

  1995cited by this paper
• High levels of a retinoic acid-generating dehydrogenase in the meso-telencephalic dopamine system.

  1994cited by this paper
• Elevation of neuronal MAO-B activity in a transgenic mouse model does not increase sensitivity to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

  1994cited by this paper
• Dopaminergic neurons in rat ventral midbrain express brain‐derived neurotrophic factor and neurotrophin‐3 mRNAs

  1994cited by this paper
• Expression of the mRNA for the rat NMDA receptor (NMDAR1) in the sensory and autonomic ganglion neurons.

  1992cited by this paper
• Localization of insulin-like growth factor I (IGF-I)-like immunoreactivity in the developing and adult rat brain.

  1991cited by this paper
• Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

  1988cited by this paper
• MPTP Effects on Dopamine Neurons

  1988cited by this paper
• Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP.

  1987cited by this paper
• Differential responsiveness to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in sub-regions of the primate substantia nigra and striatum.

  1987cited by this paper
• The inhibition site of MPP+, the neurotoxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is near the Q-binding site of NADH dehydrogenase.

  1987cited by this paper
• The role of MAO in MPTP toxicity--a review.

  1986cited by this paper
• N-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine (MPTP) causes destruction of the nigrostriatal but not the mesolimbic dopamine system in the monkey.

  1984cited by this paper
• MPTP-induced parkinsonism in human and non-human primates--clinical and experimental aspects.

  1984cited by this paper
• Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.

  1983cited by this paper

• Inhibition of de novo ceramide synthesis mitigates alpha-synuclein pathology in a Parkinson’s disease mouse model

  2026cites this paper
• The small GTPase Rit2 modulates LRRK2 kinase activity, is required for lysosomal function and protects against alpha-synuclein neuropathology

  2023cites this paper
• Transcriptome Analysis of Induced Pluripotent Stem Cells and Neuronal Progenitor Cells, Derived from Discordant Monozygotic Twins with Parkinson’s Disease

  2021cites this paper
• Repeated mild traumatic brain injury induces persistent variations in mitochondrial DNA copy number in mesocorticolimbic neurocircuitry of the rat.

  2020cites this paper
• Elevated COUP-TFII expression in dopaminergic neurons accelerates the progression of Parkinson’s disease through mitochondrial dysfunction

  2020cites this paper
• A role for glia maturation factor dependent activation of mast cells and microglia in MPTP induced dopamine loss and behavioural deficits in mice.

  2020cites this paper
• RIT2 reduces LRRK2 kinase activity and protects against alpha-synuclein neuropathology

  2020influential citation
• Contribution of cholinergic innervation to adult hippocampal neurogenesis in dementia

  2019influential citation
• Subregional differences in astrocytes underlie selective neurodegeneration or protection in Parkinson's disease models in culture

  2019cites this paper
• A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer’s disease

  2018cites this paper
• Regional microglia are transcriptionally distinct but similarly exacerbate neurodegeneration in a culture model of Parkinson’s disease

  2018cites this paper
• Discovery of Novel Cell Surface Markers for Purification of Embryonic Dopamine Progenitors for Transplantation in Parkinson's Disease Animal Models

  2018cites this paper
• A molecular network of the aging brain implicates INPPL1 and PLXNB1 in Alzheimer’s disease

  2017cites this paper
• Does MPTP intoxication in mice induce metabolite changes in the nucleus accumbens ? A 1 H nuclear magnetic resonance spectroscopy study

  2017cites this paper
• Recovery from experimental parkinsonism by intrastriatal application of erythropoietin or EPO‐releasing neural precursors

  2017cites this paper
• The Age-Related Effect of Nicotine on the Expression of Neuroprotective Genes in Ventral Tegmental Area and Substantia Nigra

  2017cites this paper
• A Single Neonatal Exposure to BMAA in a Rat Model Produces Neuropathology Consistent with Neurodegenerative Diseases

  2017cites this paper
• Neuroprotective Effect of Coptis chinensis in MPP[Formula: see text] and MPTP-Induced Parkinson's Disease Models.

  2016cites this paper
• Cross-Laboratory Analysis of Brain Cell Type Transcriptomes with Applications to Interpretation of Bulk Tissue Data

  2016cites this paper
• NeuroExpresso: A cross-laboratory database of brain cell-type expression profiles with applications to marker gene identification and bulk brain tissue transcriptome interpretation

  2016cites this paper
• Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson’s Disease

  2016influential citation
• Dopaminergic Neurodegeneration in the Mouse Is Associated with Decrease of Viscoelasticity of Substantia Nigra Tissue

  2016cites this paper
• Identification of Neurodegenerative Factors Using Translatome-Regulatory Network Analysis

  2015cites this paper
• Executive function deficits and glutamatergic protein alterations in a progressive 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson's disease

  2015cites this paper
• Mouse models rarely mimic the transcriptome of human neurodegenerative diseases: A systematic bioinformatics-based critique of preclinical models.

  2015cites this paper
• Molecular determinants of selective dopaminergic vulnerability in Parkinson’s disease: an update

  2014cites this paper
• Adult Bone Marrow Neural Crest Stem Cells and Mesenchymal Stem Cells Are Not Able to Replace Lost Neurons in Acute MPTP-Lesioned Mice

  2013cites this paper
• Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.

  2013cites this paper
• Does MPTP intoxication in mice induce metabolite changes in the nucleus accumbens? A 1H nuclear MRS study

  2013cites this paper
• Gremlin is a novel VTA derived neuroprotective factor for dopamine neurons.

  2013cites this paper
• Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients.

  2011cites this paper